SCHRODER INVESTMENT MANAGEMENT GROUP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 63 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2017$350,000
+25.9%
101,463
-8.5%
0.00%0.0%
Q2 2017$278,000
-53.7%
110,939
-50.0%
0.00%0.0%
Q1 2017$600,000
+86.3%
221,878
+100.0%
0.00%0.0%
Q4 2016$322,000
-29.4%
110,9390.0%0.00%0.0%
Q3 2016$456,000
+29.9%
110,9390.0%0.00%0.0%
Q2 2016$351,000110,9390.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders